The preoperative platelet to neutrophil ratio and lymphocyte to monocyte ratio are superior prognostic indicators compared with other inflammatory biomarkers in ovarian cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Qian,Song

第一单位： Department of Clinical Laboratory, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.

作者： Qian,Song ^[1] ; Song-Xiao,Xu ^[1] ; Jun-Zhou,Wu ^[2] ; Lin,Ling ^[3] ; Sheng,Wang ^[1] ; Xin-Hua,Shu ^[1] ; Dan-Ni,Ying ^[1] ; Wang-Wei,Pei ^[1] ; Yu-Chen,Wu ^[1] ; Su-Fang,Sun ^[1] ; Yi-Ning,Zhang ^[1] ; Si-Hang,Zhou ^[1] ; Zhu-Yan,Shao ^[4]

作者单位： Department of Clinical Laboratory, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China. ^[1] Cancer Research Institute, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China. ^[2] Department of Gynaecology, Haining People's Hospital, Haining, Zhejiang, China. ^[3] Department of Gynecological Oncology, Zhejiang Cancer Hospital, The Key Laboratory of Zhejiang Province for Aptamers and Theranostics, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China. ^[4]

关键词 lymphocyte to monocyte ratio neutrophil to lymphocyte ratio ovarian cancer platelet to lymphocyte ratio platelet to neutrophil ratio prognosis systemic immune-inflammation index